Evidence map›Paper›PMID 31692899›Full record

ArticleOncotarget2019

Correction: Hypericin targets osteoclast and prevents breast cancer-induced bone metastasis via NFATc1 signaling pathway.

Zhengxiao Ouyang, Xiaoning Guo, Xia Chen, Bo Liu, Qiang Zhang, Ziqing Yin, Zanjing Zhai, Xinhua Qu, Xuqiang Liu, Dan Peng and 3 more

Abstract readPublished Erratum
PubMed Full text at PMC Publisher
In one paragraph

Article in Oncotarget, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

13 authors.

Zhengxiao OuyangDepartment of Orthopedics, The Second Xiangya Hospital, Central South University, Changsha, Hunan, P.R. China.
Xiaoning GuoDepartment of Orthopedics, The Second Xiangya Hospital, Central South University, Changsha, Hunan, P.R. China.
Xia ChenDepartment of Orthopedics, The Second Xiangya Hospital, Central South University, Changsha, Hunan, P.R. China.
Bo LiuDepartment of Orthopedics, The Second Xiangya Hospital, Central South University, Changsha, Hunan, P.R. China.
Qiang ZhangDepartment of Orthopedics, The Second Xiangya Hospital, Central South University, Changsha, Hunan, P.R. China.
Ziqing YinDepartment of Orthopedics, The Second Xiangya Hospital, Central South University, Changsha, Hunan, P.R. China.
Zanjing ZhaiDepartment of Orthopedics, Shanghai Ninth People's Hospital, Shanghai Jiaotong University School of Medicine, Shanghai, P.R. China.
Xinhua QuDepartment of Orthopedics, Shanghai Ninth People's Hospital, Shanghai Jiaotong University School of Medicine, Shanghai, P.R. China.
Xuqiang LiuDepartment of Orthopedics, The First Affiliated Hospital of Nanchang University, Artificial Joints Engineering and Technology Research Center of Jiangxi Province, Nanchang, Jiangxi, P.R. China.
Dan PengDepartment of Orthopedics, The Second Xiangya Hospital, Central South University, Changsha, Hunan, P.R. China.
Yi ShenDepartment of Orthopedics, The Second Xiangya Hospital, Central South University, Changsha, Hunan, P.R. China.
Tang Liu *Department of Orthopedics, The Second Xiangya Hospital, Central South University, Changsha, Hunan, P.R. China.
Qing Zhang *Department of Orthopedics, The Second Xiangya Hospital, Central South University, Changsha, Hunan, P.R. China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

[This corrects the article DOI: 10.18632/oncotarget.22930.].

Identifiers

PMID31692899
PMCPMC6817446

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.